The growing importance of mTORC1-S6K1 signaling in kidney

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 3, 2009, Pages

  Siroky, Brian J ^a   Bitzer, Markus ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; RAPAMYCIN; S6 KINASE; UNCLASSIFIED DRUG;

CELL CYCLE REGULATION; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DISEASE COURSE; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY GRAFT REJECTION; KIDNEY HYPERTROPHY; KIDNEY SIZE; KNOCKOUT MOUSE; NEGATIVE FEEDBACK; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINEPHRECTOMY; UPREGULATION;

EID: 69449085207     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00357.2009     Document Type: Editorial

References (15)

1. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065-3074, 2008.
2. Chen JK, Chen J, Neilson EG, Harris RC. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol 16: 1384-1391, 2005. (Pubitemid 41716522)
3. Chen JK, Chen J, Thomas G, Kozma SC, Harris RC. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 297: F585-F593, 2009.
4. Choo AY, Blenis J. Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 8: 567-572, 2009.
5. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifi- cally blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236, 1992.
6. Grant S. Cotargeting survival signaling pathways in cancer. J Clin Invest 118: 3003-3006, 2008.
7. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument- Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175, 2002. (Pubitemid 34876545)
8. Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument- Bromage H, Tempst P, Sabatini DM. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell 11: 895-904, 2003. (Pubitemid 36566312)
9. Kinkade CW, Castillo-Martin M, Puzio-Kuter A, Yan J, Foster TH, Gao H, Sun Y, Ouyang X, Gerald WL, Cordon-Cardo C, Abate-Shen C. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. J Clin Invest 118: 3051-3064, 2008.
10. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, Rama I, Vidal A, Grinyo JM. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 17: 1395-1404, 2006. (Pubitemid 43673420)
11. Plas DR, Thomas G. Tubers and tumors: rapamycin therapy for benign and malignant tumors. Curr Opin Cell Biol 21: 230-236, 2009.
12. Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. Isolation of a protein target of the FKBP12- rapamycin complex in mammalian cells. J Biol Chem 270: 815-822, 1995.
13. Sakaguchi M, Isono M, Isshiki K, Sugimoto T, Koya D, Kashiwagi A. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem Biophys Res Commun 340: 296-301, 2006. (Pubitemid 41827680)
14. Seyer-Hansen K. Renal hypertrophy in experimental diabetes: a comparison to compensatory hypertrophy. Diabetologia 14: 325-328, 1978. (Pubitemid 8321894)
15. Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 27: 495-502, 2007. (Pubitemid 47482007)